{"id":"https://openalex.org/W2129632295","doi":"https://doi.org/10.1002/jcb.240590902","title":"Strategies for phase II cancer chemoprevention trials: Cervix, endometrium, and ovary","display_name":"Strategies for phase II cancer chemoprevention trials: Cervix, endometrium, and ovary","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W2129632295","doi":"https://doi.org/10.1002/jcb.240590902","mag":"2129632295","pmid":"https://pubmed.ncbi.nlm.nih.gov/8747372"},"language":"en","primary_location":{"id":"doi:10.1002/jcb.240590902","doi":"https://doi.org/10.1002/jcb.240590902","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jcb.240590902","pdf_url":null,"source":{"id":"https://openalex.org/S53807158","display_name":"Journal of Cellular Biochemistry","issn_l":"0730-2312","issn":["0730-2312","1097-4644"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cellular Biochemistry","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048308941","display_name":"Gary J. Kelloff","orcid":"https://orcid.org/0000-0002-5656-4900","observed_orcids":["https://orcid.org/0000-0002-5656-4900"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gary J. Kelloff","raw_affiliation_strings":["Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111645316","display_name":"Charles W. Boone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles W. Boone","raw_affiliation_strings":["Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113560256","display_name":"James A. Crowell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James A. Crowell","raw_affiliation_strings":["Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060902912","display_name":"Susan Nayfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan G. Nayfield","raw_affiliation_strings":["Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015008352","display_name":"Ernest T. Hawk","orcid":"https://orcid.org/0000-0002-9062-7338","observed_orcids":["https://orcid.org/0000-0002-9062-7338"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ernest Hawk","raw_affiliation_strings":["Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","Clinical Cancer Prevention"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Clinical Cancer Prevention","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109095551","display_name":"Vernon E. Steele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vernon E. Steele","raw_affiliation_strings":["Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014024059","display_name":"Ronald A. Lubet","orcid":"https://orcid.org/0000-0003-1957-7945","observed_orcids":["https://orcid.org/0000-0003-1957-7945"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald A. Lubet","raw_affiliation_strings":["Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemoprevention Branch (CB), Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059928711","display_name":"Caroline C. Sigman","orcid":"https://orcid.org/0000-0001-6623-4107","observed_orcids":["https://orcid.org/0000-0001-6623-4107"]},"institutions":[{"id":"https://openalex.org/I4210120487","display_name":"CCS Associates (United States)","ror":"https://ror.org/02d33pz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120487"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline C. Sigman","raw_affiliation_strings":["CCS Associates, Mountain View, CA 94043","CCS Associates"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCS Associates, Mountain View, CA 94043","institution_ids":["https://openalex.org/I4210120487"]},{"raw_affiliation_string":"CCS Associates","institution_ids":["https://openalex.org/I4210120487"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5048308941"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"],"apc_list":{"value":5110,"currency":"USD","value_usd":5110},"apc_paid":null,"fwci":0.7305,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.63128492,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"59","issue":"S23","first_page":"1","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.3522999882698059,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.3522999882698059,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.15600000321865082,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.14880000054836273,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemoprevention","display_name":"chemoprevention","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.9279999732971191},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7400000095367432},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cervical-intraepithelial-neoplasia","display_name":"cervical intraepithelial neoplasia","score":0.949999988079071},{"id":"https://openalex.org/keywords/atypical-endometrial-hyperplasia","display_name":"atypical endometrial hyperplasia","score":0.9150000214576721},{"id":"https://openalex.org/keywords/human-papillomavirus","display_name":"human papillomavirus","score":0.38999998569488525},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.8539999723434448},{"id":"https://openalex.org/keywords/antiestrogens","display_name":"antiestrogens","score":0.734000027179718},{"id":"https://openalex.org/keywords/progestins","display_name":"progestins","score":0.9819999933242798},{"id":"https://openalex.org/keywords/oral-contraceptives","display_name":"oral contraceptives","score":0.9860000014305115},{"id":"https://openalex.org/keywords/oxidative-damage","display_name":"oxidative damage","score":0.44699999690055847},{"id":"https://openalex.org/keywords/biomarker-panel","display_name":"biomarker panel","score":0.7039999961853027},{"id":"https://openalex.org/keywords/trial-design-and-conduct","display_name":"trial design and conduct","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7767826914787292},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6642102599143982},{"id":"https://openalex.org/C2778220009","wikidata":"https://www.wikidata.org/wiki/Q160105","display_name":"Cervical cancer","level":3,"score":0.6076701879501343},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.5650104284286499},{"id":"https://openalex.org/C2777740455","wikidata":"https://www.wikidata.org/wiki/Q666412","display_name":"Cervix","level":3,"score":0.5443200469017029},{"id":"https://openalex.org/C2780234812","wikidata":"https://www.wikidata.org/wiki/Q1787013","display_name":"Cancer prevention","level":3,"score":0.5335747599601746},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5115826725959778},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5108818411827087},{"id":"https://openalex.org/C2777343196","wikidata":"https://www.wikidata.org/wiki/Q196788","display_name":"Cervical intraepithelial neoplasia","level":4,"score":0.474497526884079},{"id":"https://openalex.org/C2779742232","wikidata":"https://www.wikidata.org/wiki/Q839508","display_name":"Endometrium","level":2,"score":0.4544648230075836},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45295581221580505},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3618612289428711}],"mesh":[{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/jcb.240590902","doi":"https://doi.org/10.1002/jcb.240590902","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jcb.240590902","pdf_url":null,"source":{"id":"https://openalex.org/S53807158","display_name":"Journal of Cellular Biochemistry","issn_l":"0730-2312","issn":["0730-2312","1097-4644"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cellular Biochemistry","raw_type":"journal-article"},{"id":"pmid:8747372","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8747372","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cellular biochemistry. Supplement","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W12204205","https://openalex.org/W121553317","https://openalex.org/W590862190","https://openalex.org/W1624679392","https://openalex.org/W1840193583","https://openalex.org/W1996293390","https://openalex.org/W1997715361","https://openalex.org/W2002946843","https://openalex.org/W2005765764","https://openalex.org/W2010317565","https://openalex.org/W2011762675","https://openalex.org/W2012603529","https://openalex.org/W2018581695","https://openalex.org/W2031949208","https://openalex.org/W2032219494","https://openalex.org/W2036142297","https://openalex.org/W2037204225","https://openalex.org/W2040527385","https://openalex.org/W2046041844","https://openalex.org/W2056459926","https://openalex.org/W2060602949","https://openalex.org/W2070533822","https://openalex.org/W2075960224","https://openalex.org/W2086199722","https://openalex.org/W2091004422","https://openalex.org/W2099275396","https://openalex.org/W2099309860","https://openalex.org/W2107855445","https://openalex.org/W2110121630","https://openalex.org/W2123576923","https://openalex.org/W2144958748","https://openalex.org/W2145584839","https://openalex.org/W2161356660","https://openalex.org/W2184431203","https://openalex.org/W2186183955","https://openalex.org/W2322213171","https://openalex.org/W2402257559","https://openalex.org/W2409496467","https://openalex.org/W4238255918"],"related_works":["https://openalex.org/W2018581695","https://openalex.org/W1963903539","https://openalex.org/W1744285115","https://openalex.org/W1547840953","https://openalex.org/W2139323561","https://openalex.org/W4290764004","https://openalex.org/W2104483087","https://openalex.org/W2049994941","https://openalex.org/W2094183836","https://openalex.org/W7099523956"],"abstract_inverted_index":{"Well-designed":[0],"and":[1,21,29,60,89,141,194,208,266,284,294,298,314,449,474,485,512,519,525,532],"conducted":[2],"Phase":[3,223],"II":[4,224],"clinical":[5,167],"trials":[6,415],"are":[7,48,160,254,328,480,497],"very":[8],"important":[9,369,455],"to":[10,123,154,248,273,300,310,318,330,370,419,429,457,472,477],"cancer":[11,42,78,102,136,150,302,379,473],"chemoprevention":[12,75],"drug":[13],"development.":[14],"Three":[15],"critical":[16],"aspects":[17],"govern":[18],"the":[19,46,65,99,115,164,188,192,195,200,227,240,274,278,344,355,391,422,431,435,450],"design":[20],"conduct":[22],"of":[23,76,98,117,191,242,343,350,357,402,434,463,482,487,521],"these":[24,72,216],"trials--well-characterized":[25],"agents,":[26,283],"suitable":[27,185],"cohorts,":[28],"reliable":[30],"biomarkers":[31,197,253,327,374,426,438,456,464,503,527],"for":[32,41,45,64,74,186,221,237,252,277],"measuring":[33,187],"efficacy":[34],"that":[35,70,92,112,171,255,375,384,406,427,465,496],"can":[36,445],"serve":[37],"as":[38,332,364,500,529],"surrogate":[39,333,365,501],"endpoints":[40],"incidence.":[43,137,303],"Requirements":[44],"agent":[47,193],"experimental":[49],"or":[50,270,340,386,394,410,424],"epidemiological":[51],"data":[52],"showing":[53],"chemopreventive":[54,66,145,162,177,189,282],"efficacy,":[55],"safety":[56],"on":[57,269,337,373,390],"chronic":[58],"administration,":[59],"a":[61,219,222,323,341],"mechanistic":[62],"rationale":[63],"activity":[67,116,190],"observed.":[68],"Agents":[69],"meet":[71],"criteria":[73,251],"cervical":[77,101,204],"include":[79,400,504],"antiproliferative":[80],"drugs":[81],"(e.g.,":[82],"2-difluoromethylornithine),":[83],"retinoids,":[84,172],"folic":[85],"acid,":[86],"antioxidant":[87],"vitamins":[88],"other":[90],"agents":[91,111],"prevent":[93],"cellular":[94,404,488],"oxidative":[95],"damage.":[96],"Because":[97],"significant":[100],"risk":[103,151],"associated":[104,134,396],"with":[105,114,135,203,212,288,397],"human":[106],"papilloma":[107],"virus":[108],"(HPV)":[109],"infection,":[110],"interfere":[113],"HPV":[118],"products":[119],"may":[120,143,175,290,360,385,387,407],"also":[121,169],"prove":[122,361],"be":[124,144,176,184,291,389,408,417,430,440,446,458,478],"effective":[125],"chemopreventives.":[126],"In":[127,199],"endometrium,":[128,210],"unopposed":[129],"estrogen":[130],"exposure":[131],"has":[132],"been":[133],"Thus,":[138],"pure":[139],"antiestrogens":[140],"progestins":[142],"in":[146,163,178,209,226,264,307],"this":[147,179],"tissue.":[148,180],"Ovarian":[149],"is":[152,229,234,245,322,368],"correlated":[153],"ovulation":[155],"frequency;":[156],"therefore,":[157],"oral":[158],"contraceptives":[159],"potentially":[161,498],"ovary.":[165],"Recent":[166],"observations":[168],"suggest":[170],"particularly":[173,352],"all-trans-N-4-hydroxyphenylretinamide,":[174],"The":[181,250],"cohort":[182,220],"should":[183,416,439],"intermediate":[196],"chosen.":[198],"cervix,":[201],"patients":[202,211],"intraepithelial":[205,483],"neoplasia":[206,484],"(CIN)":[207],"atypical":[213],"hyperplasia,":[214],"fit":[215,257],"criteria.":[217],"Defining":[218],"trial":[225],"ovary":[228],"more":[230,246,362,454],"difficult.":[231],"This":[232],"tissue":[233],"less":[235],"accessible":[236],"biopsy;":[238],"consequently,":[239],"presence":[241],"precancerous":[243],"lesions":[244],"difficult":[247,329],"confirm.":[249],"they":[256,444],"expected":[258],"biological":[259,313],"mechanisms":[260],"(i.e.,":[261],"differential":[262],"expression":[263],"normal":[265,403],"high-risk":[267],"tissue,":[268],"closely":[271],"linked":[272],"causal":[275,347,392],"pathway":[276,393],"cancer,":[279],"modulated":[280],"by":[281,492],"short":[285],"latency":[286],"compared":[287],"cancer),":[289],"assayed":[292],"reliably":[293],"quantitatively,":[295],"measured":[296],"easily,":[297],"correlate":[299],"decrease":[301],"They":[304],"must":[305],"occur":[306],"sufficient":[308],"incidence":[309],"allow":[311],"their":[312,469,475],"statistical":[315],"evaluation":[316],"relevant":[317],"cancer.":[319,436],"Since":[320],"carcinogenesis":[321,358],"multipath":[324],"process,":[325],"single":[326],"validate":[331],"endpoints,":[334],"perhaps":[335],"appearing":[336],"only":[338,442],"one":[339],"few":[342],"many":[345],"possible":[346],"pathways.":[348],"Panels":[349],"biomarkers,":[351],"those":[353],"representing":[354],"range":[356],"pathways,":[359],"useful":[363,499],"endpoints.":[366],"It":[367],"avoid":[371],"solely":[372],"do":[376],"not":[377,388],"describe":[378],"but":[380],"represent":[381],"isolated":[382],"events":[383],"otherwise":[395],"carcinogenesis.":[398,413],"These":[399],"markers":[401],"processes":[405],"increased":[409],"expressed":[411],"during":[412],"Chemoprevention":[414],"designed":[418],"evaluate":[420],"fully":[421],"two":[423],"three":[425],"appear":[428],"best":[432],"models":[433],"Additional":[437],"considered":[441],"if":[443],"analyzed":[447],"efficiently":[448],"sample":[451],"size":[452,518],"allows":[453],"evaluated":[459],"completely.":[460],"Two":[461],"types":[462],"stand":[466],"out":[467],"regarding":[468],"high":[470],"correlation":[471],"ability":[476],"quantified":[479],"measures":[481],"indicators":[486],"proliferation.":[489],"Measurements":[490],"made":[491],"computer-assisted":[493],"image":[494],"analysis":[495],"endpoint":[502],"nuclear":[505,508],"polymorphism":[506],"comprising":[507],"size,":[509],"shape":[510],"(roundness),":[511],"texture":[513],"(DNA":[514],"distribution":[515],"patterns);":[516],"nucleolar":[517],"number":[520],"nucleoli/nuclei;":[522],"DNA":[523],"ploidy,":[524],"proliferation":[526],"such":[528],"S-phase":[530],"fraction":[531],"PCNA...":[533]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}